Zagreb, Croatia

Vera Gomercic

This inventor holds 1 USPTO granted patent. Top assignee: Pliva Farmaceutska. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vera Gomercic. Retrieved from https://idiyas.com/inventor/vera-gomercic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vera Gomercic: Innovator in Pharmaceutical Chemistry

Introduction

Vera Gomercic is a notable inventor based in Zagreb, YU. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on peptidoglycan derivatives. Her research has implications for immunomodulation and immunoadjuvant therapies in both humans and animals.

Latest Patents

Vera holds 1 patent for her invention titled "N-acyl derivatives of the peptidoglycan monomer." This patent describes a process for preparing N-acyl derivatives of the peptidoglycan monomer, which includes various acyl groups derived from straight-chain, branched-chain, unsaturated, and aromatic carboxylic acids. The resulting compounds and their pharmaceutically acceptable salts are particularly indicated for use as immunomodulators and immunoadjuvants.

Career Highlights

Vera is currently associated with Pliva Farmaceutska, a prominent pharmaceutical company. Her work at Pliva has allowed her to focus on the development of innovative pharmaceutical solutions that address critical health challenges.

Collaborations

Throughout her career, Vera has collaborated with esteemed colleagues such as Bozidar Suskovic and Radmila Naumski. These collaborations have enriched her research and contributed to the advancement of pharmaceutical sciences.

Conclusion

Vera Gomercic's contributions to pharmaceutical chemistry, particularly through her patented innovations, highlight her role as a key figure in the field. Her work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…